International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7951210
Original Article
Study of Port Site Infections and Complications Post Various Laparoscopic Surgeries
 ,
 ,
 ,
 ,
Published
May 19, 2023
Abstract
Background: The objective of this study was to determine the incidence of port site infections and associated risk factors among patients undergoing laparoscopic surgeries. Methods: A retrospective chart review was conducted on 285 patients who underwent laparoscopic surgeries in a tertiary care hospital from January 2022 to December 2022. Data on patient demographics, surgical characteristics, and incidence of port site infections and associated complications were collected. Statistical analysis was performed to determine the risk factors for port site infections and associated complications. Results: The majority of the patients were between 31-50 years old (44.2%), and cholecystectomy was the most common type of surgery (35.0%). Out of 285 patients, 20 (7%) developed port site infections, with hernia repair having the highest incidence (9%). Superficial incisional SSIs were the most common type of infection (3.5%). The odds ratios for age, gender, BMI, and underlying medical conditions were not statistically significant. However, the odds ratio for the duration of surgery was 1.19, indicating that longer surgery duration may increase the risk of port site infections and associated complications. Conclusion: The findings of this study suggest that the risk of developing port site infections varies depending on the type of laparoscopic surgery, with longer surgery duration possibly increasing the risk. While there were no statistically significant associations found between age, gender, BMI, and underlying medical conditions with the risk of port site infections and associated complications, patients with comorbidities may be at a higher risk. Further research is needed to identify additional risk factors and develop strategies to reduce the incidence of port site infections.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2869 Views
75 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved